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Situation

Assessment

• Over the last 2 years, the Bone and Joint Center has focused on
blood utilization for total knee and total hip arthroplasty. With the use
of a blood transfusion protocol, we significantly reduced blood
transfusion rates and standardized the approach to care.
• As an expansion of this work, other ideas to further decrease blood
utilization were considered.
• The purpose of the data collection of preoperative and postoperative
Hemoglobin (Hgb) levels was to evaluate the effect of Tranexamic
Acid(TXA) on the average change in Hgb levels compared to Hgb
levels of patients that did not receive the medication. In addition, a
review of the consistency of practice for Hgb draws and review of the
quality of patient care related to the number of lab draws, cost to the
patient, and blood re-infusion per drain were recognized as other
opportunities.
• The use of a post-operative drain has been shown to be associated
with an additional cost to the patient and hospital, increased length of
stay, possible risk of infection, potential increase in blood loss and
increase in the need for a blood transfusion.
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Background
• Varied techniques such as preoperative autologous donation,
blood re-infusion per drain postoperatively, and blood algorithms
have been utilized to reduce blood loss and/or the need for a
blood transfusion after total knee arthroplasty .
• In review of literature, one grade level A article and three grade
level B articles, support the use of TXA to reduce the risk of
infection, decrease length of stay, minimize postoperative blood
loss and decrease the cost associated with blood transfusions
via blood bank and/or drain reinfusion.
• TXA is a synthetic antifibrinolytic agent that has successfully
been used to reduce blood loss following total knee replacement
and to decrease the need for a blood transfusion. This
medication can be administered intraoperatively either
intravenously or topically (intra-articular).
• Through the work on a core measure for Disease Specific Care
Certification, the blood transfusion rate for elective total knee
and total hip replacement decreased from 20% in FY 2012 to 5%
in FY 2013, with an estimated cost savings of $150,000.
• Discussion at Department of Orthopedics with key stakeholders
from perioperative services, OR, and Bone and Joint on benefits
of TXA to reduce blood loss and blood utilization postoperatively.
Some orthopedic surgeons initiated the use of TXA after this
discussion and discontinued the use of a blood salvage drain or
changed to a non re-infusable drain, constavac.
• Acuity of patients is higher due to the drain in place and the
need to re-infuse, time for vital sign monitoring, and removal of
the drain. This results in increased cost related to nursing time
and staff needed to care for the patient.

Overall Avg. Change in Hgb from Pre-Op to POD 2 = 3.5

Overall Avg. Change in Hgb from Pre-Op to POD 2 = 2.5

•

(N=34)

We defined our patient population by comparing 34 total
knee arthroplasty cases of one orthopedic surgeon ,
surgery dates of February 1st to April 22nd, 2013 preimplementation of TXA compared to 25 cases from April
23rd to June 25th, 2013 post-implementation of TXA.
We compared the average change in preoperative Hgb
level to day after surgery level. The average change in
Hgb level from day of surgery to day after surgery, along
with day after surgery and post-operative day 2 were
evaluated.
The overall average decrease in the Hgb level from preop to POD 2 was 1.0 less in the TXA group.
The percent of patients requiring a re-infusion per drain
postoperatively that did not receive TXA was 69%
compared to 8% for patients that did receive TXA. Of
the patients that did not receive TXA, 24 had a drain reinfusion . There were only 2 patients that received TXA
and had a drain re-infusion for 150 ml each .
Since December 2013, surgeons have discontinued the
routine usage of the reinfusion drain in elective total
knee arthroplasty. TXA is utilized in majority of these
cases and either a non-reinfusable drain or no drain.
There is also a significant cost savings of salary dollars,
due to decreasing nursing time for preparation and reinfusion per drain, monitoring of vitals, and
discontinuation of the drain. On average patients
received one reinfusion per drain initiated in a 6 hour
time period postoperatively.

(N= 25)

Recommendation
Patient
Scenario

Charge per case

Savings
per case

Tranexamic Acid and
Blood Salvage Drain

$584.69

N/A

Tranexamic Acid and
Constavac Drain

$373.95

$210.74

Tranexamic Acid and no drain

$260.72

$323.97

Estimated Total Savings in one year, considering an average
of 500 Total Knee Arthroplasty cases per year =

$161,985

Future considerations:
• Utilize TXA to decrease decline of Hgb level
postoperatively and decrease drain blood loss.
• Decrease or eliminate routine usage of a re-infusion or
constavac drain.
• Possibly administer TXA in other types of orthopedic
procedures such as fracture repair and total shoulder
replacement.
• Incorporate order for TXA into preop order sets to
increase awareness and accessibility of the medication
in OR.
• Evaluate the need for the number of Hgb draws
postoperatively and decrease frequency as appropriate.
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